Interface Biologics
- Headquarters
- Toronto
- Business Model
- B2B
- Total Funding
- $8.0M
- Last Round
- $1.0M Series BJan 2015
- Rounds
- 4
About
Toronto-based biomaterials company developing surface modification technology to prevent clots on medical implants.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Jan 2015
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...